Log in to save to my catalogue

Powder X-ray diffraction of pazopanib hydrochloride Form 1, C21H24N7O2SCl

Powder X-ray diffraction of pazopanib hydrochloride Form 1, C21H24N7O2SCl

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2569607756

Powder X-ray diffraction of pazopanib hydrochloride Form 1, C21H24N7O2SCl

About this item

Full title

Powder X-ray diffraction of pazopanib hydrochloride Form 1, C21H24N7O2SCl

Publisher

New York, USA: Cambridge University Press

Journal title

Powder diffraction, 2021-09, Vol.36 (3), p.205-207

Language

English

Formats

Publication information

Publisher

New York, USA: Cambridge University Press

More information

Scope and Contents

Contents

The crystal structure of pazopanib hydrochloride Form 1 has been refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Pazopanib hydrochloride crystallizes in space group P-1 (#2) with a = 8.45008(6), b = 8.71310(12), c = 16.05489(35) Å, α = 79.5996(9), β = 86.4784(5), γ = 87.3764(3)°, V =...

Alternative Titles

Full title

Powder X-ray diffraction of pazopanib hydrochloride Form 1, C21H24N7O2SCl

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2569607756

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2569607756

Other Identifiers

ISSN

0885-7156

E-ISSN

1945-7413

DOI

10.1017/S0885715621000282

How to access this item